Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Oxford is to take part in three new government-funded projects designed to help universities collaborate with each other, and with external organisations, to boost research commercialisation.

None

Image courtesy of Shutterstock

Healthy ageing, the internet of things, and commercialisation in the social sciences are the three themes with involvement from Oxford academics. Oxford is leading the programme on healthy ageing, is a partner in the Sheffield University-led internet of things project, and will also participate in the social sciences initiative led by LSE.

The projects are funded via Research England (formerly the Higher Education Funding Council for England) through its Connecting Capability Fund (CCF). This £100m fund supports university collaboration in research commercialisation with the aims of sharing good practice across the higher education sector, forging external technological, industrial and regional partnerships, and helping deliver the government's industrial strategy priorities.

Oxford recently launched its 150th spinout company based on University research. In 2018 alone, six new companies have been formed and more than £150m has been raised in external investment.

Professor Chas Bountra of Oxford's Nuffield Department of Clinical Medicine is leading the healthy ageing programme, titled UK SPINE KE and also involving Birmingham and Dundee universities. Announced last autumn in the first wave of CCF awards, the £4.82m project will establish a UK-wide network across universities, businesses and the NHS focused on improving health in old age.

Find out more (University of Oxford website)

Similar stories

Regular meat consumption linked with a wide range of common diseases

Research

Regular meat consumption is associated with a range of diseases that researchers had not previously considered, according to a large, population-level study conducted by a team at the University of Oxford.

New data show vaccines reduce severe COVID-19 in older adults

Coronavirus COVID-19 Research

New data show both Oxford / AstraZeneca vaccine and the Pfizer-BioNTech vaccines significantly reduce severe COVID-19 in older adults.

Singula Bio, a new Oxford spin-out company - Cancer need not be fatal

General Innovation Research

Singula Bio, a bold new seed-stage biotechnology company spun out of Oxford University, has been launched with the intention of helping show that cancer need not be fatal. Led by three Oxford cancer specialists, the firm is aims to become a world leader in therapies to use against difficult-to-treat solid malignancies such as ovarian cancer - using the body’s own immune system to fight previously fatal cancers.

Major rise in public support for COVID vaccine – Oxford study

Coronavirus COVID-19 General Research

More than three quarters of people in the UK now say they are ’very likely’ to have the vaccine – up from 50% among the same group of survey respondents five months ago –according to a two-wave Oxford University survey published today.

Coronavirus vaccination linked to substantial reduction in hospitalisation, real-world data suggests

Coronavirus COVID-19 General Research

The first study to describe the effects in real-world communities of the Oxford coronavirus vaccine has been reported in a pre-print publication today, showing a clear reduction in the risk of hospitalisation from COVID-19 amongst those who have received the vaccine.